Telephone
N/A
Address
2nd Floor 13-15 Bouverie Street Harmsworth House London, Greater London EC4Y 8DP
Description
Doctor Care Anywhere Group PLC is a telehealth company, which engages in delivering care to its patients, whilst reducing the overall cost of providing clinical services. It operates through the following segments: Primary Care, Secondary Care, and Remote Care. The Primary Care segment includes general practice, pharmacy, dental, and optician services. The Secondary Care segment covers medical specialties and levels of clinical acuity, meaning the severity of a patient's illness or condition which determines the level of attention or service they will need from professional staff. The Remote Care segment involves the use of remote medical devices that track patients’ health data and report results automatically. The company was founded by Bayju Thakar and David Jeremy Ravech on February 27, 2014 and is headquartered in London, the United Kingdom.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.04 - 0.09
Trade Value (12mth)
US$2,302.00
1 week
-5.8%
1 month
-5.8%
YTD
4.84%
1 year
14.04%
All time high
1.52
EPS 3 yr Growth
-89.000%
EBITDA Margin
-2.10%
Operating Cashflow
-£6m
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
367m
HALO Sector
Healthcare
Next Company Report Date
26-Feb-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
GBP
Short Sell (% of issue)
0.01
Date | Announcements |
---|---|
12 July 24 |
Notification regarding unquoted securities - DOC
×
Notification regarding unquoted securities - DOC |
17 June 24 |
Change in substantial holding from TEK
×
Change in substantial holding from TEK |
17 June 24 |
Change in substantial holding from Tiga Trading Pty Ltd
×
Change in substantial holding from Tiga Trading Pty Ltd |
13 June 24 |
Guidance Upgrade for H1 2024 Revenue Growth
×
Guidance Upgrade for H1 2024 Revenue Growth |
30 April 24 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
29 April 24 |
Annual General Meeting - Presentations and Addresses
×
Annual General Meeting - Presentations and Addresses |
24 April 24 |
Quarterly Activities Report / Appendix 4C Cash Flow Report
×
Quarterly Activities Report / Appendix 4C Cash Flow Report |
11 April 24 |
AGM Reminder
×
AGM Reminder |
05 April 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
28 March 24 |
2023 Annual Report & Corporate Governance Statement
×
2023 Annual Report & Corporate Governance Statement |
28 March 24 |
Appendix 4G
×
Appendix 4G |
20 March 24 |
Launches diagnostic test partnership with Medichecks
×
Launches diagnostic test partnership with Medichecks |
12 March 24 |
Initial Director's Interest Notice - Ben Kent
×
Initial Director's Interest Notice - Ben Kent |
07 March 24 |
Change of Director's Interest Notice - John Stier UPDATE
×
Change of Director's Interest Notice - John Stier UPDATE |
07 March 24 |
CEO & CFO Appointment
×
CEO & CFO Appointment |
06 March 24 |
Change of Director's Interest Notice - John Stier
×
Change of Director's Interest Notice - John Stier |
04 March 24 |
Notification regarding unquoted securities - DOC
×
Notification regarding unquoted securities - DOC |
29 February 24 |
Appendix 4E FY23 Preliminary Final Report
×
Appendix 4E FY23 Preliminary Final Report |
29 February 24 |
Investor Presentation FY23 Results
×
Investor Presentation FY23 Results |
09 February 24 |
Change in substantial holding from TEK
×
Change in substantial holding from TEK |
09 February 24 |
Change in substantial holding from Tiga Trading Pty Ltd
×
Change in substantial holding from Tiga Trading Pty Ltd |
01 February 24 |
Company Secretary Appointment/Resignation
×
Company Secretary Appointment/Resignation |
31 January 24 |
Quarterly Activities Report / Appendix 4C Cash Flow Report
×
Quarterly Activities Report / Appendix 4C Cash Flow Report |
15 January 24 |
Notification regarding unquoted securities - DOC
×
Notification regarding unquoted securities - DOC |
12 January 24 |
Completion of Convertible Loan Note Financing
×
Completion of Convertible Loan Note Financing |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.